[Evaluation of the effectiveness of Uro-Vaxom in recurrent urinary tract infections in children].

Abstract

The aim of the study was to determine the effectiveness of Uro-Vaxom in the treatment in children with recurrent urinary tract infections induced by E. coli. Our investigations confirmed that in the group of children receiving pharmacotherapy and Uro-Vaxom, a significant increase of sIgA in the urine was found, lasting for at least 3 months. During this period no infection appeared in 92% of the examined children. The authors recommend including Uro-Vaxom in the therapy of children, because it is effective and well-tolerated by children.

• Authors: M Czerwionka-Szaflarska, M Pawłowska
• Journal: Pediatria polska (Pediatr Pol) Vol. 71 Issue 7 Pg. 599-604 (Jul 1996) ISSN: 0031-3939 [Print] Poland
• Vernacular Title: Ocena skuteczności Uro-Vaxomu w nawracajacych zakazeniach układu moczowego u dzieci.
• PMID: 8803463 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)

Chemical References

• Adjuvants, Immunologic
• Anti-Bacterial Agents
• Anti-Infective Agents, Urinary
• Immunoglobulin A

Topics

• Adjuvants, Immunologic (therapeutic use)
• Anti-Bacterial Agents (therapeutic use)
• Anti-Infective Agents, Urinary (therapeutic use)
• Child
• Child, Preschool
• Escherichia coli
• Escherichia coli Infections (drug therapy, immunology)
• Female
• Humans
• Immunoglobulin A (urine)
• Male
• Recurrence
• Urinary Tract Infections (drug therapy, immunology)